Radiation therapy firm North American Scientific (NAS) reported that it plans to enter the developing market for breast brachytherapy through an initiative designed to improve on current accelerated partial-breast irradiation (APBI) treatment options.
NAS said it has filed for patent protection and is completing design of a multichannel catheter device that can be placed following surgery and prior to initiation of radiation treatment. The new device is designed to accommodate treatments at high-dose or low-dose rates, according to the Chatsworth, CA-based firm.
In addition, the company has submitted a 510(k) application to the Food and Drug Administration for a device that delivers a low-dose-rate treatment utilizing its Prospera brachytherapy seeds. The developer said it expects to file a second 510(k) application with the FDA to market a similar device for the high-dose-rate procedure.
NAS currently plans to launch its new APBI devices this November at the 2006 meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) conference in Philadelphia.
By AuntMinnie.com staff writers
March 21, 2006
Related Reading
NAS gets Nasdaq noncompliance notice, March 20, 2006
NAS cuts losses in Q1, March 10, 2006
NAS receives Chinese clearance for IGRT device, February 21, 2006
NAS gets FDA clearance for brachytherapy needle kit, February 7, 2006
NAS fiscal 2005 results impacted by Nomos purchase, January 10, 2006
Copyright © 2006 AuntMinnie.com
